AB Science will host a live webcast on Tuesday May 25, 2021 on masitinib results in Prostate Cancer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PRESS RELEASE
AB SCIENCE WILL HOST A LIVE WEBCAST ON TUESDAY MAY 25, 2021 ON MASITINIB’S RESULTS IN PROSTATE CANCER
Paris, May 21, 2021, 6pm CET
AB Science SA (Euronext – FR0010557264 – AB) will host a live webcast on May 25, 2021 with key opinion leaders to discuss recently reported results from the Phase 2B/3 masitinib trial in prostate cancer.
The webcast call will be held on Tuesday May 25, 2021 from 6.30pm to 7.30pm CET (12.30pm to 1.30pm ET).
The webcast will feature presentations by three Key Opinion Leaders:
Stéphane Oudard, MD, PhD, Chief of the Oncology Clinical and Translational Research Unit at the Georges Pompidou Hospital in Paris, France
Message :
Required fields
Except for statements of historical fact, certain information described in this
Form 10-Q report contains forward-looking statements that involve substantial
risks and uncertainties. You can identify these statements by forward-looking
words such as anticipate, believe, could, estimate, expect, intend, may, should, will, would or similar words. The statements that contain
these or similar words should be read carefully because these statements discuss
the Company s future expectations, including its expectations of its future
results of operations or financial position, or state other forward-looking
information.
Vivos Inc. believes that it is important to communicate its future
expectations to its investors. However, there may be events in the future that
Princess Dina succeeds Prince Albert as honorary president of EORTC
Princess Dina is a global advocate for cancer control and non-communicable diseases
By JT - Apr 21,2021 - Last updated at Apr 21,2021
AMMAN HRH Princess Dina Mired has been appointed as the honorary president of the European Organisation for Research and Treatment of Cancer (EORTC).
Princess Dina succeeds Prince Albert II of Monaco who has held the presidency since 2014 during which significant efforts have been made to advance EORTC’s mission of improving survival and quality of life for cancer patients, according to a statement from the organisation.
Since 1962, EORTC has contributed and continue to deliver therapeutic progress to cancer patients, the statement said.
Scandion Oncology engages former ASCO executive as clinical advisor
Scandion Oncology is pleased to announce that we have appointed Dr. Richard L. Schilsky, a seasoned and highly profiled international leader as a member of our clinical advisory board (CAB). Dr. Schilsky is the former CMO and Executive Vice President of the American Society of Clinical Oncology (ASCO) and a long-time faculty member of the University of Chicago.
Scandion Oncology A/S
Publicerad: 21 april 2021, 11:30
Copenhagen, April 21, 2021. Scandion Oncology, The Cancer Drug Resistance Company, is pleased to announce that
Richard L. Schilsky, MD, FACP, FSCT, FASCO has accepted to join the clinical advisory board of Scandion Oncology.